Heat loads and cryogenics for HE-LHC

We report preliminary considerations on cryogenics for a higher-energy LHC ("HE-LHC") with about 16.5 TeV beam energy and 20-T dipole magnets. In particular we sketch the heat loads scaled on the proposed principal beam parameters and size the cryogenic plants for different operating temperature of the beam screens.Comment: 4 pages, contribution to the EuCARD-AccNet-EuroLumi Workshop: The High-Energy Large Hadron Collider, Malta, 14 -- 16 Oct 201

Technical Analysis and Statistics from Long Term Helium Cryoplant Operation with Experimental Superconducting Magnets at CERN

CERN regularly uses a large number of liquid helium cryoplants for cooling the superconducting magnets of large particle detectors. They are installed in the experimental areas of the electron-positron collider LEP and the proton (and heavy ion) accelerator SPS for the observation of high-energy interactions of elementary particles. The typical cold mass of a detector magnet ranges from 1 to 40 tons, and typical cryoplant cooling capacities are between 400 and 800 W/4.5 K entropy equivalent. Operation must be very flexible to meet the varying experimental requirements. We intend to present technical data of the system and statistics from over 180'000 running hours during the four years from 1992 to 1995. Operation includes phases of cool-down, steady-state cooling, recovery after magnet quench or other incidents and warm-up of the superconducting magnets. Emphasis will be laid on the analysis of fault conditions, multiple interaction between perturbations and consequences for the users of liquid helium supply interruption

Conclusions from 12 Years Operational Experience of the Cryoplants for the Superconducting Magnets of the LEP Experiments

The Large Electron Positron Collider (LEP) has ended its last physics run in November 2000, and it is at present being dismantled to liberate the tunnel for the Large Hadron Collider (LHC) project to be completed by end of 2005. The cryogenic systems for the superconducting solenoid and focusing quadrupoles for the two LEP experiments, ALEPH and DELPHI, each supplying a cooling power of 800 W/4.5 K entropy equivalent, have accumulated more then 100'000 hours of running time. The paper summarises the 12 years cryogenic experience in the various operating modes: cool-down, steady state, recovery after energy fast dump, utilities failures and warm-up of the superconducting magnets. The detailed operation statistics is presented and compared to the other CERN cryogenic systems. Emphasis is given to the technical analysis of the fault conditions and of their consequences on the helium refrigeration production time in view of the future operation of the LHC cryogenics

New Long-term Historical Data Recording and Failure Analysis System for the CERN Cryoplants

CERN uses several liquid helium cryoplants (total of 21) for cooling large variety of superconducting devices namely: accelerating cavities, magnets for accelerators and particle detectors. The cryoplants are remotely operated from several control rooms using industrial standard supervision systems, which allows the instant display of all plant data and the trends, over several days, for the most important signals. The monitoring of the cryoplant performance during transient conditions and normal operation over several months asks for a long-term recording of all plant parameters. An historical data recording system has been developed, which collects data from all cryoplants, stores them in a centralized database over a period of one year and allows an user-friendly graphical visualization. In particular, a novel tool was developed for debugging causes of plant failures by comparing selected reference data with the simultaneous evolution of all plant data. The paper describes the new system, already in operation with 11 cryoplants

Cryogenics for the Large Hadron Collider Experiments

High Energy Physics experiments have frequently adopted cryogenic versions of their apparatus to achieve the desired performance. Among the four new experiments for the CERN Large Hadron Collider (LHC) the two largest, ATLAS and CMS, include spectrometers using 4.5 K superconducting magnets and detectors filled with liquid argon at 87 K, respectively for particle momentum and energy measurements. These detectors are of unprecedented size and complexity and the definition of the associated cryogenic systems is the result of a collaboration between CERN and several external institutes all around the world. A review of the various systems is presented with particular emphasis to the basic cooling principles, the special cryogenic features and the operation scenarios

The cryogenic system for the superconducting solenoid magnet of the CMS experiment

The design concept of the CMS experiment, foreseen for the Large Hadron Collider (LHC) project at CERN, is based on a superconducting solenoid magnet. The large coil will be made of a four layers winding generating the 4 T uniform magnetic induction required by the detector. The length of the solenoid is 13 m with an inner diameter of 5.9 m. The mass kept at liquid helium temperature totals 220 t and the electromagnetic stored energy is 2.7 GJ. The windings are indirectly cooled with a liquid helium flow driven by a thermosyphon effect. The external cryogenic system consists of a 1.5 kW at 4.5 K (entropy equivalent) cryoplant including an additional liquid nitrogen precooling unit and a 5000 litre liquid helium buffer. The whole magnet and cryogenic system will be tested at the surface by 2003 before final installation in the underground area of LHC

New cryogenic facilities for testing superconducting equipments for the CERN Large Hadron Collider

CERN's major project, the Large Hadron Collider (LHC), has moved to an implementation phase with machine construction to be completed by 2005. To achieve the design proton-proton centre of mass energy of 14 TeV in the given 27 km circumference LEP tunnel, the LHC will make an extensive use of high-field superconducting magnets using Nb-Ti filament operated at 1.9 K. In order to test, on the one han d, the superconducting cables of the magnets and, on the other hand, the expected performance of several of these magnets assembled in a string representing the lattice period of the machine (107 m lo ng), CERN has installed new cryogenic test facilities. The paper briefly describes these new facilities with all their associated equipments

Cryogenics for CERN experiments: past, present and future

Use of cryogenics at CERN was originated (in the 1960s) by bubble chambers and the associated s.c. solenoids. Complex cryoplants were installed to provide cooling at LH2 and LHe temperatures. Continuity (in the 1970s) in He cryogenics for experiments was provided by spectrometer magnets for fixed target physics of the SPS accelerator. More recently (in the 1980s), large "particle-transparent" s.c. solenoids for collider experiments (LEP) have been built demanding new cryoplants. The LHC experiments (in the 2000s) will continue the tradition with s.c. dipoles (ALICE and LHCb), solenoids (CMS, ATLAS) and toroids (ATLAS) of unusual size. Cryogenics for experiments using noble liquids follows the same trend since the development (in the 1970s) of the first shower LAr detectors. A LKr calorimeter (about 10 m3) will be operated in 1996 and the ATLAS experiment foresees a set of three huge LAr calorimeters (almost 90 m3 total volume of liquid) to be installed underground

A study of empyema thoracis and role of intrapleural streptokinase in its management

BACKGROUND: Clinical spectrum, microbiology and outcome of empyema thoracis are changing. Intrapleural instillation of fibrinolytic agents is being increasingly used for management of empyema thoracis. The present study was carried out to describe the clinical profile and outcome of patients with empyema thoracis including those with chronic empyema and to study the efficacy and safety of intrapleural streptokinase in its management. METHODS: Clinical profile, etiological agents, hospital course and outcome of 31 patients (mean age 40 ± 16 years, M: F 25: 6) with empyema thoracis treated from 1998 to 2003 was analyzed. All patients were diagnosed on the basis of aspiration of frank pus from pleural cavity. Clinical profile, response to therapy and outcome were compared between the patients who received intrapleural streptokinase (n = 12) and those who did not (n = 19). RESULTS: Etiology was tubercular in 42% of the patients (n = 13) whereas the rest were bacterial. Amongst the patients in which organisms could be isolated (n = 13, 42%) Staphylococcus aureus was the commonest (n = 5). Intrapleural streptokinase was instilled in 12 patients. This procedure resulted in increase of drainage of pleural fluid in all patients. Mean daily pleural fluid drainage after streptokinase instillation was significantly higher for patients who received intrapleural streptokinase than those who did not (213 ml vs 57 ml, p = 0.006). Only one patient who was instilled streptokinase eventually required decortication, which had to be done in five patients (16.1%). Mean hospital stay was 30.2 ± 17.6 days whereas two patients died. CONCLUSIONS: Tubercular empyema is common in Indian patients. Intrapleural streptokinase appears to be a useful strategy to preserve lung function and reduce need for surgery in patients with late stage of empyema thoracis